Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms
RSC Pharmaceutics · 2026 · 3 (3) · 768-777
DOI: 10.1039/d6pm00014b ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Gaurav Awasthi und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
In silico studies were combined with in vitro validation to u nderstand the landscape of DEIs for further development of a stable solid oral dosage form.
Zitieren
APA
Awasthi, G., & Banerjee, S. (2026). Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms. RSC Pharmaceutics, 3(3), 768-777. https://doi.org/10.1039/d6pm00014b
Vancouver
Awasthi G, Banerjee S. Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms. RSC Pharmaceutics. 2026;3(3):768-777. doi:10.1039/d6pm00014b
BibTeX
@article{Awasthi2026,
author = {Awasthi, Gaurav and Banerjee, Subham},
title = {Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {3},
pages = {768--777},
doi = {10.1039/d6pm00014b}
}
EUVIMED